The Jerusalem PostBennett 'very optimistic' at unity tent as Eisenkot bloc weighs coalition with NetanyahuPunch2027: Akwa Ibom gov promises renovation of school, market upgradeInquirerPalace slams Sara Duterte camp for linking gov’t to threat vs ex-stafferInquirer EntertainmentFrom ‘Twilight’ fandom to 007 megastar: Robert Pattinson takes on James BondBollywood HungamaAvengers: Doomsday sets another RECORD; Navi Mumbai multiplex sells ticket for Rs. 4,300; price of a single ticket crosses Rs. 4,000 mark for the FIRST time ever!ZDF heuteEntdecken Sie das ZDF-NachrichtenstudioIl Fatto QuotidianoSciopero generale Cgil del 20 novembre: dai trasporti alla scuola, chi si ferma e perchéVarietySchiwago Film Boards ‘Southwest’ Starring Avi Nash and Antoine Reinartz and ‘Anatol’ and Readies Tallinn Bow of ‘The Matriarch’ (EXCLUSIVE)NMEElon Musk hits out at ‘SNL’ impression of him: “I’d give them maybe five out of 10”7sur7“Mes collègues s’y attendaient”: Mathias a pris quatre jours de congé pour la sortie de GTA VIBBC NewsPretending to be in New Zeland, booking leave and buying consoles - the lengths fans are going to for GTA 6Rai NewsTG3 Fuori TG del 17/11/2026
The Daily Newsstand · Free, Always
Tuesday, November 17, 2026

New Viagra-like drug could slow down decline of Alzheimer’s

Translate

A medication that works in a similar way to Viagra could help slow cognitive decline in Alzheimer’s patients, new research indicates.

Designed for people with early-stage Alzheimer’s disease, the pill AR1001 was shown to reduce clinical deterioration by 31 per cent in a specific cohort of patients receiving no other treatments.

AR1001 is a phosphodiesterase-5 inhibitor, a drug class prescribed for erectile dysfunction or pulmonary high blood pressure.

AriBio, the South Korean firm behind the AR1001 tablet, stated that the treatment slowed decline among 604 people taking no other Alzheimer’s therapies.

In a broader group receiving other medications, however, the tablet failed to deliver any statistically significant trial results.

New Viagra-like drug could slow down decline of Alzheimer’s

New Viagra-like drug could slow down decline of Alzheimer’s (Getty/iStock)

Dr Richard Oakley, associate director for research and innovation at Alzheimer’s Society in the UK, said: “These topline results are an exciting sign that we could have a totally new treatment for early Alzheimer’s disease that tackles its causes, not just its symptoms.

“AR1001 takes a novel approach, relaxing blood vessels to increase blood flow to the brain.

“And unlike other disease-modifying treatments that have shown benefit in late-stage trials, it is taken as a once-a-day tablet, which could make treatment simpler.

“Over the year of the trial, this drug was able to effectively slow down people’s decline in memory and thinking by nearly a third, and the side effects reported were mostly mild to moderate.

“However, the drug doesn’t seem to be as effective for people taking other drugs for Alzheimer’s symptoms, so this needs further investigation.

“AR1001 is from the same family of medicines as Viagra, but it is being developed specifically for Alzheimer’s disease. People should not take Viagra to try to treat Alzheimer’s.

“It’s also important to note AR1001 is not yet available to the public and will need to be assessed and approved by UK regulatory bodies before it could be offered in the UK.

“Research is making huge progress and will beat dementia – and as more potential treatments emerge, it’s more important than ever that people get an early and accurate dementia diagnosis so they can benefit from them.

“We look forward to seeing the full results from this trial and how this drug progresses.”

View the original on The Independent →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.